J. Good

681 total citations
14 papers, 296 citations indexed

About

J. Good is a scholar working on Oncology, Radiation and Molecular Biology. According to data from OpenAlex, J. Good has authored 14 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Radiation and 4 papers in Molecular Biology. Recurrent topics in J. Good's work include Advanced Radiotherapy Techniques (5 papers), Head and Neck Cancer Studies (3 papers) and Cancer Genomics and Diagnostics (2 papers). J. Good is often cited by papers focused on Advanced Radiotherapy Techniques (5 papers), Head and Neck Cancer Studies (3 papers) and Cancer Genomics and Diagnostics (2 papers). J. Good collaborates with scholars based in United Kingdom, United States and Belgium. J. Good's co-authors include Kevin J. Harrington, Magnus T. Dillon, S. Parmar, Sean Loughran, Paul Pracy, Liu C, Lukasz Witek, Vasudev Vivekanand Nayak, Paul Sanghera and A. Hartley and has published in prestigious journals such as Biomaterials, Annals of Oncology and Protein & Cell.

In The Last Decade

J. Good

13 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Good United Kingdom	8	98	95	73	58	56	14	296
Yuanhu Yao China	8	62 0.6×	79 0.8×	67 0.9×	39 0.7×	40 0.7×	25	234
Ruifang Zeng China	10	136 1.4×	81 0.9×	106 1.5×	31 0.5×	125 2.2×	18	366
Naritoshi Mukumoto Japan	9	70 0.7×	67 0.7×	154 2.1×	64 1.1×	65 1.2×	26	312
Zeming Mo China	7	78 0.8×	164 1.7×	113 1.5×	46 0.8×	143 2.6×	11	369
Shadhvi S. Bhairosingh Netherlands	10	59 0.6×	101 1.1×	91 1.2×	46 0.8×	12 0.2×	19	298
Sophie Brackrock Germany	7	137 1.4×	84 0.9×	82 1.1×	134 2.3×	43 0.8×	8	333
Michael Wittlinger Germany	8	77 0.8×	152 1.6×	66 0.9×	22 0.4×	32 0.6×	14	381
Jing Jin China	11	110 1.1×	119 1.3×	79 1.1×	31 0.5×	12 0.2×	39	352
Yaping Xu China	13	59 0.6×	236 2.5×	358 4.9×	76 1.3×	19 0.3×	44	523
Rafke Schoffelen Netherlands	10	58 0.6×	209 2.2×	59 0.8×	230 4.0×	14 0.3×	12	430

Countries citing papers authored by J. Good

Since Specialization

Citations

This map shows the geographic impact of J. Good's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Good with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Good more than expected).

Fields of papers citing papers by J. Good

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Good. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Good. The network helps show where J. Good may publish in the future.

Co-authorship network of co-authors of J. Good

This figure shows the co-authorship network connecting the top 25 collaborators of J. Good. A scholar is included among the top collaborators of J. Good based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Good. J. Good is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hasan, Sadaf, et al.. (2025). Exogenous pyruvate is therapeutic against colitis by targeting cytosolic phospholipase A2. Genes & Diseases. 12(5). 101571–101571. 2 indexed citations

Hasan, Sadaf, et al.. (2024). Dietary pyruvate targets cytosolic phospholipase A2 to mitigate inflammation and obesity in mice. Protein & Cell. 15(9). 661–685. 9 indexed citations

Mukherjee, Somnath, et al.. (2024). Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: First Reported Clinical Outcomes From the UK. Clinical Oncology. 36(9). 576–584.

Witek, Lukasz, et al.. (2023). Injectable hydrogel for sustained delivery of progranulin derivative Atsttrin in treating diabetic fracture healing. Biomaterials. 301. 122289–122289. 39 indexed citations

Gough, Jessica, et al.. (2022). Technical Radiotherapy Advances – The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation. Clinical Oncology. 34(5). 301–312. 5 indexed citations

Aitken, K., J. Good, M. Hawkins, et al.. (2020). Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic. Clinical Oncology. 32(7). 477–477. 4 indexed citations

Harrington, Kevin J., Shreerang Bhide, Martin Förster, et al.. (2020). Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer. Clinical Oncology. 32(8). 490–492. 1 indexed citations

Reed, Nick, Hilary Glen, Gareth Gerrard, et al.. (2019). Expert Consensus on the Management of Adverse Events During Treatment with Lenvatinib for Thyroid Cancer. Clinical Oncology. 32(5). e145–e153. 20 indexed citations

Sanghera, Paul, et al.. (2017). Implementing Head and Neck Contouring Peer Review without Pathway Delay: The On-demand Approach. Clinical Oncology. 29(12). 841–847. 13 indexed citations

10.

Zandberg, Dan P., Alain P. Algazi, Antonio Jimeno, et al.. (2017). Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study. Annals of Oncology. 28. v372–v372. 24 indexed citations

11.

Meade, Susanna, et al.. (2017). A prospective comparison of common toxicity criteria adverse events Version 3 and 4 in assessing oral mucositis for oral and oropharyngeal carcinoma. Technical Innovations & Patient Support in Radiation Oncology. 1. 18–21. 6 indexed citations

12.

Pracy, Paul, et al.. (2016). Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. The Journal of Laryngology & Otology. 130(S2). S104–S110. 42 indexed citations

13.

Dillon, Magnus T., J. Good, & Kevin J. Harrington. (2014). Selective Targeting of the G2/M Cell Cycle Checkpoint to Improve the Therapeutic Index of Radiotherapy. Clinical Oncology. 26(5). 257–265. 76 indexed citations

14.

Good, J. & Kevin J. Harrington. (2013). The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology. Clinical Oncology. 25(10). 569–577. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact